The United Laboratories International Holdings Limited
OTC: ULIHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hoi Shan Tsoi
- Employees
- 17,000
- Headquarters
- Yuen Long, Hong Kong SAR China
- IPO year
- 2014
- Market cap
- $2.4B
- Website
- https://www.tul.com.cn
Loading ULIHF…
Loading profile data…Frequently asked questions about ULIHF
What does The United Laboratories International Holdings Limited (ULIHF) do?
The United Laboratories International Holdings Limited functions as a pharmaceutical investment holding company, overseeing the entire spectrum of drug-related activities from initial research and development to manufacturing, distribution, and sales. Its business operations are structured into three main divisions: Bulk Medicine, Intermediate P...
Where does ULIHF trade?
The United Laboratories International Holdings Limited (ULIHF) trades on the Other OTC.
What sector is ULIHF in?
The United Laboratories International Holdings Limited (ULIHF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of The United Laboratories International Holdings Limited?
Hoi Shan Tsoi is the chief executive officer of The United Laboratories International Holdings Limited (ULIHF).
Where is The United Laboratories International Holdings Limited headquartered?
The United Laboratories International Holdings Limited is headquartered in Hong Kong SAR China.
Does ULIHF pay a dividend?
Yes — The United Laboratories International Holdings Limited (ULIHF) paid a trailing twelve-month dividend of USD 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ULIHF go public?
The United Laboratories International Holdings Limited (ULIHF) completed its initial public offering in 2014.